rs727503769
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM5PP2BP4_Moderate
The NM_133433.4(NIPBL):c.4321G>A(p.Val1441Ile) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000435 in 1,380,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1441L) has been classified as Pathogenic.
Frequency
Consequence
NM_133433.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPBL | NM_133433.4 | c.4321G>A | p.Val1441Ile | missense_variant, splice_region_variant | 20/47 | ENST00000282516.13 | NP_597677.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPBL | ENST00000282516.13 | c.4321G>A | p.Val1441Ile | missense_variant, splice_region_variant | 20/47 | 1 | NM_133433.4 | ENSP00000282516 | P1 | |
NIPBL | ENST00000448238.2 | c.4321G>A | p.Val1441Ile | missense_variant, splice_region_variant | 20/46 | 1 | ENSP00000406266 | |||
NIPBL | ENST00000652901.1 | c.4321G>A | p.Val1441Ile | missense_variant, splice_region_variant | 20/46 | ENSP00000499536 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152000Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249810Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135450
GnomAD4 exome AF: 0.00000326 AC: 4AN: 1228562Hom.: 0 Cov.: 18 AF XY: 0.00000321 AC XY: 2AN XY: 622976
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152000Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74238
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 08, 2019 | The p.V1441I variant (also known as c.4321G>A) is located in coding exon 19 of the NIPBL gene. The valine at codon 1441 is replaced by isoleucine, an amino acid with highly similar properties. This change occurs in the first base pair of coding exon 19. This amino acid position is highly conserved in available vertebrate species; however, isoleucine is the reference amino acid in other vertebrate species. This variant did not co-segregate with disease in multiple individuals tested in our laboratory (Ambry internal data). Based on four different splice site prediction tools, this alteration is expected to abolish or weaken the native splice acceptor site; however experimental evidence is not currently available. A different alteration located at the same position, p.V1441L (c.4321G>T), has been detected as de novo in three separate individuals: one with classic Cornelia de Lange Syndrome (CdLS), and two others both with mild CdLS phenotypes (Pié J et al. Am. J. Med. Genet. A, 2010 Apr;152A:924-9; Zhong Q et al. Genet Test Mol Biomarkers, 2012 Sep;16:1130-4; Kuzniacka A et al. J. Appl. Genet., 2013 Feb;54:27-33). In addition, the p.V1441I alteration is predicted to be benign and tolerated by PolyPhen and SIFT in silico analyses, respectively. Since supporting evidence is conflicting at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at